Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
97 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Keimyung University-Dongsan Medical Center
Jung-Ku, Daegu, South Korea
- Samsung Medical Center
Seoul, Korea, South Korea
- Asan Medical Center
Seoul, South Korea
- Gangnam Severance Hospital
Seoul, South Korea
- Korea Cancer Center Hospital
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- John Muir Medical Center-Walnut Creek
Walnut Creek, California, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Sudarshan K Sharma Md Limited-Gynecologic Oncology
Hinsdale, Illinois, United States
- Elkhart Clinic
Elkhart, Indiana, United States
- Elkhart General Hospital
Elkhart, Indiana, United States
- Michiana Hematology Oncology Pc-Elkhart
Elkhart, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Community Howard Regional Health
Kokomo, Indiana, United States
- Iu Health la Porte Hospital
La Porte, Indiana, United States
- Michiana Hematology Oncology Pc-Mishawaka
Mishawaka, Indiana, United States
- Saint Joseph Regional Medical Center-Mishawaka
Mishawaka, Indiana, United States
- Michiana Hematology Oncology Pc-Plymouth
Plymouth, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Michiana Hematology Oncology Pc-South Bend
South Bend, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- South Bend Clinic
South Bend, Indiana, United States
- Michiana Hematology Oncology Pc-Westville
Westville, Indiana, United States
- Mcfarland Clinic Pc - Ames
Ames, Iowa, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Maine Medical Center-Bramhall Campus
Portland, Maine, United States
- Michigan Cancer Research Consortium Ncorp
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Beaumont Hospital - Dearborn
Dearborn, Michigan, United States
- Ascension Saint John Hospital
Detroit, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Apr 2010
- Primary completion
- 1 May 2014
- Completion
- 9 Feb 2019
- Last update posted
- 19 Feb 2020
- Registered enrollment
- 35
- Registry id
- NCT00979992
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.